Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
View the MNPR historical prices.
The 52 Week Low is $0.27 set on Thu, Sep 22, 2022.
The 52 Week High is $1.75 set on Tue, Nov 8, 2022. The current price, $0.66, is 0% below the 52 Week High.
The All-Time High is $48.00 set on Fri, Dec 20, 2019. The current price, $0.66, is 0% below the All Time High.
MNPR has no dividend history.
Annual Dividend Yield
Quarterly Dividend Rate
Declaration Date
Ex-Dividend Date
Record Date
Payment Date
Dividend Frequency
Dividend History
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
Did you know you can earn $30 back on your first $30 of qualifying purchases with Rakuten?
Join now and start saving on every purchase from top retailers like Target, eBay, Zappos, Walmart, Kohl's & CVS. Whether you're shopping for fashion, electronics, home essentials, or health products, Rakuten makes it rewarding.
Sign up through this link and explore the endless possibilities to save and earn cash back!
Check out the Symbol Surfing blog to learn about investing.